Lazar Vujanovic

10PUBLICATIONS
47CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyTumour immunologyPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 25, 2026
Tumoral and Systemic Immune Correlates of Response to Concurrent Pembrolizumab and Chemoradiotherapy in Patients with Resected High-Risk Head and Neck Squamous Cell Carcinoma.

|Dec 10, 2025
Serum Arginase-1 is a predictive biomarker for melanoma patients and a surrogate indicator of systemic myeloid cell fitness.

Matthias Brand, Juraj Adamik, Hong Wang

|May 27, 2025
Randomized Phase II Study of Concurrent Versus Sequential Pembrolizumab in Combination With Chemoradiation in Locally Advanced Head and Neck Cancer.

Dan P Zandberg, Lazar Vujanovic, David A Clump

|Jan 08, 2025
Differential impact of TIM-3 ligands on NK cell function.

Juncheng Wang, Housaiyin Li, Aditi Kulkarni

|Nov 20, 2024
CD8+ Tumor-Infiltrating Lymphocytes in Head and Neck Cancer: A Review.

Kevin J Contrera, Matthew E Spector, Liron Pantanowitz

|Aug 30, 2023
Tumor cell p38 inhibition to overcome immunotherapy resistance.

Jason J Luke, Rebekah E Dadey, Ryan C Augustin

Pageof 2

Frequent Collaborators

6 joint publications

Robert L Ferris

4 joint publications

Riyue Bao

2 joint publications

Julie E Bauman

2 joint publications

Tullia C Bruno